AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $857,550 | +0.5% | 12,270 | +3.4% | 0.00% | 0.0% |
Q2 2023 | $852,978 | +2.2% | 11,870 | -12.2% | 0.00% | 0.0% |
Q1 2023 | $834,222 | +15.7% | 13,525 | +44.7% | 0.00% | 0.0% |
Q4 2022 | $721,166 | +49.9% | 9,350 | -13.3% | 0.00% | +50.0% |
Q3 2022 | $481,000 | -25.7% | 10,790 | -36.1% | 0.00% | -33.3% |
Q2 2022 | $647,000 | +2.9% | 16,890 | +11.2% | 0.00% | +50.0% |
Q1 2022 | $629,000 | +3.5% | 15,187 | -5.6% | 0.00% | 0.0% |
Q4 2021 | $608,000 | -0.7% | 16,087 | -13.4% | 0.00% | 0.0% |
Q3 2021 | $612,000 | +6.4% | 18,577 | +117.9% | 0.00% | 0.0% |
Q2 2021 | $575,000 | +18.1% | 8,527 | -0.9% | 0.00% | 0.0% |
Q1 2021 | $487,000 | -63.2% | 8,607 | -47.1% | 0.00% | -60.0% |
Q4 2020 | $1,325,000 | +31.1% | 16,267 | +14.6% | 0.01% | +25.0% |
Q3 2020 | $1,011,000 | -12.7% | 14,192 | +0.9% | 0.00% | -33.3% |
Q2 2020 | $1,158,000 | +205.5% | 14,072 | +118.5% | 0.01% | +200.0% |
Q1 2020 | $379,000 | -79.3% | 6,440 | -63.7% | 0.00% | -77.8% |
Q4 2019 | $1,833,000 | – | 17,732 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |